Related Experiment Videos
Craniofacial resection. An analysis of 73 cases
P J Catalano1, C S Hecht, H F Biller
1Department of Otolaryngology-Head and Neck Surgery, Mount Sinai School of Medicine, New York, NY.
Archives of Otolaryngology--Head & Neck Surgery
|November 1, 1994
Summary
Craniofacial resection effectively treats paranasal sinus tumors with acceptable mortality. Morbidity rates are linked to surgical experience, with infections being the most severe complications.
Area of Science:
- Oncology
- Neurosurgery
- Otolaryngology
Background:
- Paranasal sinus tumors require complex surgical management.
- Craniofacial resection is a significant procedure for these tumors.
Purpose of the Study:
- To evaluate morbidity and mortality in patients undergoing craniofacial resection.
- To analyze outcomes based on pathology, recurrence, and adjuvant therapy.
Main Methods:
- Retrospective review of 73 patients with paranasal sinus tumors.
- Mean follow-up of 3 years.
- Morbidity categorized as early/late and by type (neurologic, ocular, infectious).
Main Results:
- Overall morbidity rate was 63%, with a 2.7% mortality rate.
- Major morbidities occurred in 26 patients.
- Common complications included altered mental status, diplopia, CSF leak, and osteomyelitis.
Conclusions:
- Craniofacial resection is an effective treatment for paranasal sinus tumors.
- Mortality is acceptable; morbidity is associated with surgical experience.
- Infectious complications were the most severe.